Kaleido Biosciences, Inc.
KLDO · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $100,045 | $304,397 | $129,030 | $418,288 |
| - Cash | $38,474 | $46,222 | $71,241 | $76,086 |
| + Debt | $21,694 | $21,009 | $20,459 | $14,922 |
| Enterprise Value | $83,265 | $279,184 | $78,248 | $357,124 |
| Revenue | $1,104 | $975 | $0 | $0 |
| % Growth | 13.2% | – | – | – |
| Gross Profit | -$1,254 | -$54,992 | -$1,318 | $0 |
| % Margin | -113.6% | -5,640.2% | – | – |
| EBITDA | -$85,092 | -$76,995 | -$84,036 | -$59,029 |
| % Margin | -7,707.6% | -7,896.9% | – | – |
| Net Income | -$90,288 | -$81,620 | -$85,013 | -$61,744 |
| % Margin | -8,178.3% | -8,371.3% | – | – |
| EPS Diluted | -2.16 | -2.44 | -3.31 | -2.1 |
| % Growth | 11.5% | 26.3% | -57.6% | – |
| Operating Cash Flow | -$77,094 | -$61,518 | -$75,796 | -$46,316 |
| Capital Expenditures | -$1,129 | -$4,024 | -$3,586 | -$3,002 |
| Free Cash Flow | -$78,223 | -$65,542 | -$79,382 | -$49,318 |